Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

ONCR

Oncorus (ONCR)

Oncorus Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ONCR
DatumZeitQuelleÜberschriftSymbolFirma
07/08/202312h52Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ONCROncorus Inc
03/08/202323h00Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:ONCROncorus Inc
03/08/202322h38Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ONCROncorus Inc
03/08/202322h36Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONCROncorus Inc
28/07/202322h40Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ONCROncorus Inc
28/07/202322h12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONCROncorus Inc
26/06/202322h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ONCROncorus Inc
23/06/202312h31Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ONCROncorus Inc
16/06/202315h21Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ONCROncorus Inc
12/06/202312h45Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:ONCROncorus Inc
09/06/202322h27Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ONCROncorus Inc
01/06/202322h35Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ONCROncorus Inc
01/06/202322h05GlobeNewswire Inc.Oncorus Announces Workforce Reduction PlanNASDAQ:ONCROncorus Inc
22/05/202323h01Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ONCROncorus Inc
22/05/202322h14Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ONCROncorus Inc
22/05/202322h05GlobeNewswire Inc.Oncorus Reports First Quarter 2023 Financial Results and Provides Business UpdatesNASDAQ:ONCROncorus Inc
18/05/202322h10Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ONCROncorus Inc
16/05/202322h38Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:ONCROncorus Inc
05/05/202323h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ONCROncorus Inc
01/05/202313h36Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:ONCROncorus Inc
01/05/202312h40Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ONCROncorus Inc
24/03/202321h08Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ONCROncorus Inc
24/03/202312h28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ONCROncorus Inc
24/03/202312h00GlobeNewswire Inc.Oncorus Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business UpdatesNASDAQ:ONCROncorus Inc
14/03/202321h29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ONCROncorus Inc
14/02/202314h05Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ONCROncorus Inc
13/02/202318h37Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ONCROncorus Inc
02/02/202320h15Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ONCROncorus Inc
04/01/202313h00GlobeNewswire Inc.Oncorus Announces Research Collaboration with Daewoong Pharmaceutical for the Development of Lipid Nanoparticle Formulations for mRNA Drug CandidatesNASDAQ:ONCROncorus Inc
28/12/202200h34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ONCROncorus Inc
 Showing the most relevant articles for your search:NASDAQ:ONCR